期刊文献+

超声在妇科肿瘤临床诊断上的价值分析

Value Analysis of Ultrasound in Clinical Diagnosis of Gynecologic Tumor
下载PDF
导出
摘要 目的:探讨超声在妇科肿瘤诊断的临床应用价值。方法回顾性分析从2009年5月~2014年12月入住我院的65例妇科肿瘤患者的术前超声资料,结合病理组织学检查的结果证实超声检查的准确性。结果本次回顾的65例患者的术前超声资料与术后病理检查相比较的结果表明,恶性肿瘤检出率为89%。良性肿瘤检出率为92%。结论超声检查诊断妇科肿瘤病变的准确性高,具有较高的临床应用价值。 Objective To investigate the clinical value of ultrasound in the diagnosis of gynecologic tumor.Methods We retrospectively investigated 65 patients suffering from gynecologic cancer from May 2009 to December 2014 admitted to our hospital,we combined the preoperative ultrasound data with histopathological examination results to confirm the accuracy of ultrasonography.Results The results of preoperative ultrasound and pathological examination were compared with the pathological examination,and the detection rate of malignant tumor was 89%. The detection rate of benign tumor was 92%. Conclusion The accuracy of diagnosis for gynecological tumor lesions is high,and it has higher clinical application value.
作者 宁海燕 王岩
出处 《中国卫生标准管理》 2015年第17期164-165,共2页 China Health Standard Management
关键词 超声 肿瘤 临床诊断 Ultrasound, Tumor, Clinical diagnosis
  • 相关文献

参考文献3

二级参考文献27

  • 1CARMELIET P,JAIN R K.Angiogenesis in cancer and other diseases[J].Nature,2000,407(6801):249-257.
  • 2FOLKMAN J.Tumor angiogenisis[J].Adv Cancer Res,1985,43:175-203.
  • 3ANGEID BACKMAN E,COLEMAN B G,ARGER P H,et al.Comparison of resistive index versus pulsatility index in assessing the benign etiology of adnexal masses[J].Clin Imaging,1998,22(4):284-291.
  • 4KURJAK A,PREDANIC M,KUPESIC UREK S,et al.Transvaginal color and pulsed Doppler assessment of adnexal tumor vascularity[J].Gynecol Oncol,1993,50(1):3-9.
  • 5BENJAPIBAL M,SUNSANEEVITYAYAKUL P,BORIBOONHIRUNSARN D,et al.Color Doppler ultrasonography for prediction of malignant ovarian tumors[J].J Med Assoc Thai,2002,85(6):709-715.
  • 6Spahn M, Weiss C, Bader P, et al. The role of exenterative surgery and urinary diversion in persistent or locally recurrent gynecological malignancy: complications and survival[ J ]. Urol Int,2010, 85(1) :16 -22.
  • 7Abdel-Azeez H A, Labib H A, Sharaf S M, et al. HE4 and mesothelin: novel biomarkers of ovarian carcinoma in patients with pelvic masses[J]. Asian Pac J Cancer Prev,2010,11 ( 1 ) :111 - 6.
  • 8Li J, Dowdy S, Tipton T, et al. HEal as a biomarker for ovarian and endometrial cancer management [ J ]. Expert Rev Mol Diagn, 2009, 9(6) :555 -66.
  • 9Tamakoshi K, Kikkawa F, Shibata K, et al. Clinical value of CA125, CA19-9, CEA, CA72-4 and TPA in borderline ovarian tumor[J]. Gynecol Oncol,1996,62( 1 ) : 67 - 72.
  • 10Sebastianelli A, Renaud M C, Gregoire J, et al. Preoperative CA 125 tumour marker in endometrial cancer: correlation with advanced stage disease [ J ].J Obstet Gynaecol Can, 2010,32 ( 9 ) : 856 - 60.

共引文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部